GDPR compliance in life sciences
Life sciences companies are grappling with heightened expectations to protect patient data while advancing medical research. Meeting General Data Protection Regulation (GDPR) requirements in 2025 demands strategic implementation of encryption, anonymization, and AI technologies. Here’s how your organization can achieve this.
FDA 21 CFR Part 11 Compliance in Life Sciences for 2025
In 2025, the life sciences industry continues to advance at a remarkable pace, driven largely by digital transformation.
Pharma compliance solutions and regulatory success
The pharmaceutical industry operates under some of the strictest oversight in the business world, where a single misstep can cost millions and derail years of research. Consequently, robust pharma compliance solutions are fundamental to ensuring regulatory success and achieving operational efficiency.
FDA takes aim at pharmaceuticals’ social media activity
The FDA is turning its eye towards pharmaceuticals’ social media use. Review the laws and regulations triggering FDA warning letters and how to stay compliant.
How a people-first plan ensures effective data governance in the age of AI
Life sciences companies are keen to utilize cutting-edge AI tools and software, but data governance programs need to be in top form first.
Four key challenges for compliant mobile communications in healthcare and life sciences
Compliance teams in healthcare and life sciences must balance both regulatory restrictions and the needs of employees to achieve compliant mobile communications with corporate devices.
